Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial - Université de Lorraine Access content directly
Journal Articles Journal of Hematology and Oncology Year : 2017

Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial

Huili Cai
  • Function : Author
  • PersonId : 772931
  • IdRef : 187826420
Hélène Jeulin
Stéphane Vigouroux
  • Function : Author
  • PersonId : 874572

Dates and versions

hal-01720707 , version 1 (01-03-2018)

Identifiers

Cite

Chongsheng Qian, Arnaud Campidelli, Yingying Wang, Huili Cai, Véronique Venard, et al.. Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial. Journal of Hematology and Oncology, 2017, 10 (1), pp.102. ⟨10.1186/s13045-017-0469-0⟩. ⟨hal-01720707⟩
103 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More